Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...

Early inflation Balloon inflates before aortic valve closes – the left ventricle is therefore forced to empty against an inflated balloon. There is an increase in afterload, potentially raising ...

Continuing the trajectory seen at 30 days and 1 year, the long-term data from the IABP-SHOCK II trial reported today show no survival benefit for intra-aortic balloon pump (IABP) use in acute MI ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

Compared with the years 2000-2009, cardiac deaths and case fatalities in U.S. marathon and half-marathon runners have come down significantly. (JAMA) People with zero of five classic cardiovascular ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in ...

PARIS, France—When used at the right time and in the right patients, intra-aortic balloon pumps (IABPs) might improve outcomes following STEMI, 6-month results from the SEMPER-FI pilot study suggest.

In the multicentre, open-label, randomized, controlled trial IABP-SHOCK II, the previously reported 30-day data demonstrated no early mortality reduction with intra-aortic balloon pump (IABP) use in ...

Please provide your email address to receive an email when new articles are posted on . In a cohort of patients who underwent high-risk PCI, mechanical circulatory support with a microaxial blood pump ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced that Maquet Datascope Corp. has recalled a hybrid intra-aortic balloon pump due to a design ...

Undersized donor hearts were indeed associated with more post-transplantation mortality -- but only among complex transplant recipients, a Nashville center found. (Annals of Thoracic Surgery) In Japan ...